The role of hyperglycemia in acute stroke

Citation
N. Kagansky et al., The role of hyperglycemia in acute stroke, ARCH NEUROL, 58(8), 2001, pp. 1209-1212
Citations number
58
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ARCHIVES OF NEUROLOGY
ISSN journal
00039942 → ACNP
Volume
58
Issue
8
Year of publication
2001
Pages
1209 - 1212
Database
ISI
SICI code
0003-9942(200108)58:8<1209:TROHIA>2.0.ZU;2-W
Abstract
Background: Ischemic stroke is a leading cause of death and long-term disab ility, and hyperglycemia is believed to aggravate cerebral ischemia. Objectives: To review animal and human studies on the relationship between hyperglycemia and brain ischemia that elucidate some of the mechanisms for the deleterious effect of hyperglycemia. To discuss present and future clin ical recommendations for glucose control. Methods: Computerized data sources and published indexes and articles from 1976 through 2000 were searched for human studies that evaluated the associ ation between stroke and hyperglycemia, and studies focused on experimental models of hyperglycemic animals with focal and global brain ischemia. Results: Most human studies have shown that in acute stroke, admission hype rglycemia in patients with or without diabetes is associated with a worse c linical outcome than in patients without hyperglycemia. This association is more consistent in the nonlacunar type of stroke. Animal studies support t hese findings by showing both in global and in focal postischemic models th at hyperglycemia exaggerates the following damaging processes: intracellula r acidosis, accumulation of extracellular glutamate, brain edema formation, blood-brain barrier disruption, and tendency for hemorrhagic transformatio n. Insulin treatment of hyperglycemic animals was found to have a beneficia l effect in focal and global brain ischemia, which may be mediated by the g lucose-reduction effect or by a direct neuroprotection. Conclusions: Most studies show the deleterious effect of early hyperglycemi a, especially in patients with nonlacunar focal or global ischemia. Clinica l trials of intensive insulin treatment are needed. Meanwhile simple measur es to avoid excessive hyperglycemia are recommended.